Immune System
1
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
Oxion BiologicsOX118 or placebo
Human BioSciencesHigh saturated fat challenge meal
Clinical Trials (2)
Total enrollment: 64 patients across 2 trials
A First-in-Human Phase I Trial of OX118 in Healthy Volunteers
Start: Apr 2025Est. completion: Oct 202532 patients
Phase 1Recruiting
Postprandial Monocyte Study
Start: Nov 2023Est. completion: Oct 202432 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 64 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.